首站-论文投稿智能助手
典型文献
The Rational Combination Strategy of Immunomodulatory Latency Reversing Agents and Novel Immunotherapy to Achieve HIV-1 Cure
文献摘要:
Human immunodeficiency virus (HIV)-1 infection creates a persistent latent reservoir even after antiretroviral therapy, which is the main barrier to HIV cure. One of the most explored strategies is the use of latent reversal agents (LRAs) to activate HIV latent reservoirs, followed by immunotherapy to remove infected cells. Immunomodulatory LRAs have the dual advantage of activating viral latency and promoting immune cell elimination of HIV-infected cells. The emergence of novel immunotherapies has also enhanced the possibility of HIV clearance. Here we review the activity and potential mechanisms of immunomodulatory agonists and immunotherapies. The possible combinational strategies to achieve HIV functional cure and the problems encountered using this approach are discussed.
文献关键词:
HIV-1;Combination strategy;Immunomodulator latency reversing agents;Immunotherapy;Shock and kill
作者姓名:
Li Yangyang;Hong Junxian;Zhang Linqi
作者机构:
NexVac Research Center, Comprehensive AIDS Research Center, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China;Joint Graduate Program of Peking-Tsinghua-NIBS, School of Life Sciences, Tsinghua University, Beijing 100084, China
引用格式:
[1]Li Yangyang;Hong Junxian;Zhang Linqi-.The Rational Combination Strategy of Immunomodulatory Latency Reversing Agents and Novel Immunotherapy to Achieve HIV-1 Cure)[J].感染性疾病和免疫(英文),2022(04):263-273
A类:
LRAs,Immunomodulator
B类:
Rational,Combination,Strategy,Immunomodulatory,Latency,Reversing,Agents,Novel,Immunotherapy,Achieve,HIV,Cure,Human,immunodeficiency,virus,infection,creates,persistent,latent,even,after,antiretroviral,which,main,barrier,cure,One,most,explored,strategies,use,reversal,agents,activate,reservoirs,followed,by,immunotherapy,remove,infected,cells,have,dual,advantage,activating,latency,promoting,immune,elimination,emergence,novel,immunotherapies,has,also,enhanced,possibility,clearance,Here,review,activity,potential,mechanisms,immunomodulatory,agonists,possible,combinational,achieve,functional,problems,encountered,using,this,approach,are,discussed,strategy,reversing,Shock,kill
AB值:
0.65824
相似文献
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Non-traumatic coma in young children in Benin: are viral and bacterial infections gaining ground on cerebral malaria?
Brisset Josselin;Baki Karl Angendu;Watier Laurence;Kinkpé Elisée;Bailly Justine;Ayédadjou Linda;Alao Maroufou Jules;Dossou-Dagba Ida;Bertin Gwladys I.;Cot Michel;Boumédiène Farid;Ajzenberg Daniel;Aubouy Agnès;Houzé Sandrine;Faucher Jean-Fran?ois;NeuroCM Group-Infectious Diseases and Tropical Medicine Department, Limoges University Hospital, 2 Avenue Martin Luther King, 87000 Limoges, France;Inserm UMR 1094, IRD U270, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Univ. Limoges, CHU Limoges, Limoges, France;Center for Research in Epidemiology and Population Health (CESP), INSERM U1018, Paris-Saclay University, UVSQ, Montigny-Le-Bretonneux, France;Epidemiology and Modeling of Bacterial Evasion to Antibacterials Unit (EMEA), Institut Pasteur, 25-28, Rue du Dr. Roux, 75724 Paris Cedex 15, France;Paediatric Department, Calavi Hospital, Calavi, Benin;UMR261 MERIT, IRD, Université de Paris, 75006 Paris, France;French Malaria Reference Center, H?pital Bichat, APHP, Paris, France;Paediatric Department, Mother and Child University and Hospital Center (CHU-MEL), Cotonou, Benin;Clinical Research Institute of Benin (IRCB), Abomey Calavi, Benin;UMR152 PHARMADEV, Université de Toulouse, IRD, UPS, Toulouse, France;Parasitology Laboratory, Hopital Bichat-Claude-Bernard, APHP, Paris, France
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study
Peng Qiaoli;Liu Xiaoning;Tang Xian;Zhang Qiuyue;Zhao Jin;Zheng Chenli;Zhao Fang;Zhou Yang;Zhang Lukun;Sun Liqin;Zhang Haitao;Jia Xinyun;Song Ying;Cao Tingzhi;Wang Siyuan;Rao Man;Chen Zhiwei;Wang Hui;He Yun-National Clinical Research Center for Infectious Diseases, HKU AIDS Institute Shenzhen Research Laboratory, The Third People’s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong 518112, China;National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom;Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong 518073, China;Department of Microbiology, AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
Li Shuang;Moog Christiane;Zhang Tong;Su Bin-Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Laboratoire d' ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg 67000, France
Clinical Features and Corrected Factors with Neurosyphilis in HIV/Syphilis Co-Infected Patients Based on Stage of Syphilis
Wang Yuan-Yuan;Shi Mei;Guan Zhi-Fang;Zhang Lei;Gu Xin;Lu Hai-Kong;Qi Teng-Fei;Ni Li-Yan;Wu Juan;Zhao Wei;Peng Rui-Rui;Zhu Lin;Zhou Ping-Yu-Sexually Transmitted Disease Institute, Shanghai Skin Disease Hospital, Clinical School of Anhui Medical University, Shanghai 200050, China;Sexually Transmitted Disease Institute, Shanghai Skin Disease Hospital, Tongji University, School of Medicine, Shanghai 200050, China;China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Centre, Xi’an, Shaanxi 710049, China;Melbourne Sexual Health Centre, Alfred Health, Melbourne 3800, Australia;Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne 3800, Australia;Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, China.
Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-KB positive feedback loop
Shuyu Xin;Lingzhi Liu;Yanling Li;Jing Yang;Lielian Zuo;Pengfei Cao;Qijia Yan;Shen Li;Li Yang;Taimei Cui;Jianhong Lu-Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,410013,China;Department of Microbiology,School of Basic Medical Science,Central South University,Changsha,410078,China;The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education,NHC Key Laboratory of Carcinogenesis,Cancer Research Institute,Central South University,Changsha 410078,China;China-Africa Research Center of Infectious Diseases,Central South University,Changsha,410013,China;Department of Hematology,National Clinical Research Center for Geriatric Disorders,Department of Pathology,Xiangya Hospital,Central South University,Changsha,410080,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。